FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293493701> ?p ?o ?g. }

• W4293493701 abstract "Abstract A novel series of 1,3‐oxazol‐4‐yltriphenylphosphonium salts has been synthesized and functionalized. Oxazole derivatives were subjected to NCI in vitro assessment. Seven most active derivatives have been selected for five‐dose assay. Among them, compounds 9 ([2‐(4‐methylphenyl)‐5‐[(4‐methylphenyl)sulfanyl]‐1,3‐oxazol‐4‐yl]triphenylphosphonium perchlorate), 1 ([5‐(4‐methylphenyl)amino]‐2‐phenyl‐1,3‐oxazol‐4‐yl]triphenylphosphonium perchlorate) and 4 ([5‐phenyl‐2‐[(4‐methylphenyl)amino]‐1,3‐oxazol‐4‐yl]triphenylphosphonium perchlorate) were the most active against all tested cancer subpanels. Statistical analysis of the total panel data showed average values of parameters of anticancer activity in the range of 0.3–1.1 μM (GI 50 ), 1.2–2.5 μM (TGI) and 5–6 μM (LC 50 ). It was found that the presence of phenyl or 4‐methylphenyl groups at C(2) and C(5) in the oxazole ring is of critical importance for the manifestation of the anticancer activity. Matrix COMPARE analysis using LC 50 vector showed a high positive correlation of compound 9 with standard anticancer agents that can directly disrupt mitochondrial function, causing programmed death of cancer cells. The obtained results indicate the anticancer activity of 1,3‐oxazol‐4‐ylphosphonium salts, which could be useful for developing new anticancer drugs. The most active of them can be recommended for further in‐depth studies and synthesis of new derivatives with antitumor activity on their basis." @default.
• W4293493701 created "2022-08-29" @default.
• W4293493701 creator A5009744325 @default.
• W4293493701 creator A5012219280 @default.
• W4293493701 creator A5027594486 @default.
• W4293493701 creator A5027704177 @default.
• W4293493701 creator A5045844172 @default.
• W4293493701 creator A5072322913 @default.
• W4293493701 date "2022-09-15" @default.
• W4293493701 modified "2023-10-18" @default.
• W4293493701 title "Evaluation of Anticancer Activity of 1,3‐Oxazol‐4‐ylphosphonium Salts <i>in Vitro</i>" @default.
• W4293493701 cites W1531237901 @default.
• W4293493701 cites W1579386532 @default.
• W4293493701 cites W1767441991 @default.
• W4293493701 cites W1859693964 @default.
• W4293493701 cites W1971601910 @default.
• W4293493701 cites W1995764804 @default.
• W4293493701 cites W1996264180 @default.
• W4293493701 cites W2003562258 @default.
• W4293493701 cites W2035246620 @default.
• W4293493701 cites W2037493669 @default.
• W4293493701 cites W2047936439 @default.
• W4293493701 cites W2089190709 @default.
• W4293493701 cites W2090900582 @default.
• W4293493701 cites W2094044830 @default.
• W4293493701 cites W2104472330 @default.
• W4293493701 cites W2119660622 @default.
• W4293493701 cites W2122560466 @default.
• W4293493701 cites W2131384584 @default.
• W4293493701 cites W2141866312 @default.
• W4293493701 cites W2154106598 @default.
• W4293493701 cites W2265062179 @default.
• W4293493701 cites W2314104762 @default.
• W4293493701 cites W2331072277 @default.
• W4293493701 cites W2428051237 @default.
• W4293493701 cites W2734341876 @default.
• W4293493701 cites W2738754485 @default.
• W4293493701 cites W2788287081 @default.
• W4293493701 cites W2792047376 @default.
• W4293493701 cites W2797485983 @default.
• W4293493701 cites W2803687733 @default.
• W4293493701 cites W2890594508 @default.
• W4293493701 cites W2896506245 @default.
• W4293493701 cites W2897054652 @default.
• W4293493701 cites W2964471788 @default.
• W4293493701 cites W2979147623 @default.
• W4293493701 cites W3011014170 @default.
• W4293493701 cites W3014089261 @default.
• W4293493701 cites W3016868439 @default.
• W4293493701 cites W3024006398 @default.
• W4293493701 cites W3034245199 @default.
• W4293493701 cites W3081371844 @default.
• W4293493701 cites W3081667723 @default.
• W4293493701 cites W3089099395 @default.
• W4293493701 cites W3096317905 @default.
• W4293493701 cites W3097322860 @default.
• W4293493701 cites W3165521089 @default.
• W4293493701 cites W3165974568 @default.
• W4293493701 cites W4200114335 @default.
• W4293493701 cites W4293493701 @default.
• W4293493701 doi "https://doi.org/10.1002/cmdc.202200319" @default.
• W4293493701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36037305" @default.
• W4293493701 hasPublicationYear "2022" @default.
• W4293493701 type Work @default.
• W4293493701 citedByCount "2" @default.
• W4293493701 countsByYear W42934937012022 @default.
• W4293493701 countsByYear W42934937012023 @default.
• W4293493701 crossrefType "journal-article" @default.
• W4293493701 hasAuthorship W4293493701A5009744325 @default.
• W4293493701 hasAuthorship W4293493701A5012219280 @default.
• W4293493701 hasAuthorship W4293493701A5027594486 @default.
• W4293493701 hasAuthorship W4293493701A5027704177 @default.
• W4293493701 hasAuthorship W4293493701A5045844172 @default.
• W4293493701 hasAuthorship W4293493701A5072322913 @default.
• W4293493701 hasBestOaLocation W42934937012 @default.
• W4293493701 hasConcept C145148216 @default.
• W4293493701 hasConcept C178790620 @default.
• W4293493701 hasConcept C185592680 @default.
• W4293493701 hasConcept C202751555 @default.
• W4293493701 hasConcept C2778203186 @default.
• W4293493701 hasConcept C2780709120 @default.
• W4293493701 hasConcept C55493867 @default.
• W4293493701 hasConcept C71240020 @default.
• W4293493701 hasConceptScore W4293493701C145148216 @default.
• W4293493701 hasConceptScore W4293493701C178790620 @default.
• W4293493701 hasConceptScore W4293493701C185592680 @default.
• W4293493701 hasConceptScore W4293493701C202751555 @default.
• W4293493701 hasConceptScore W4293493701C2778203186 @default.
• W4293493701 hasConceptScore W4293493701C2780709120 @default.
• W4293493701 hasConceptScore W4293493701C55493867 @default.
• W4293493701 hasConceptScore W4293493701C71240020 @default.
• W4293493701 hasFunder F4320318013 @default.
• W4293493701 hasFunder F4320330169 @default.
• W4293493701 hasIssue "20" @default.
• W4293493701 hasLocation W42934937011 @default.
• W4293493701 hasLocation W42934937012 @default.
• W4293493701 hasLocation W42934937013 @default.
• W4293493701 hasOpenAccess W4293493701 @default.
• W4293493701 hasPrimaryLocation W42934937011 @default.
• W4293493701 hasRelatedWork W1969087706 @default.

• next